OPTIAGLAR Trademark

Trademark Overview

On Friday, December 13, 2019, a trademark application was filed for OPTIAGLAR with the United States Patent and Trademark Office. The USPTO has given the OPTIAGLAR trademark a serial number of 88726181. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 17, 2023. This trademark is owned by Eli Lilly and Company. The OPTIAGLAR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations namely, pharmaceutical preparations for the treatment of diabetes
optiaglar

General Information

Serial Number88726181
Word MarkOPTIAGLAR
Filing DateFriday, December 13, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 17, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 21, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations namely, pharmaceutical preparations for the treatment of diabetes
Translation of Words in MarkThe wording "OPTIAGLAR" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, December 17, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285
Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events

Event DateEvent Description
Monday, July 17, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 17, 2023ABANDONMENT - NO USE STATEMENT FILED
Friday, November 18, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 17, 2022SOU EXTENSION 5 GRANTED
Wednesday, November 9, 2022SOU EXTENSION 5 FILED
Thursday, November 17, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, November 9, 2022TEAS EXTENSION RECEIVED
Friday, May 20, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 18, 2022SOU EXTENSION 4 GRANTED
Wednesday, May 18, 2022SOU EXTENSION 4 FILED
Wednesday, May 18, 2022TEAS EXTENSION RECEIVED
Tuesday, November 9, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 5, 2021SOU EXTENSION 3 GRANTED
Friday, November 5, 2021SOU EXTENSION 3 FILED
Friday, November 5, 2021TEAS EXTENSION RECEIVED
Wednesday, May 19, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 17, 2021SOU EXTENSION 2 GRANTED
Monday, May 17, 2021SOU EXTENSION 2 FILED
Monday, May 17, 2021TEAS EXTENSION RECEIVED
Wednesday, November 18, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 16, 2020SOU EXTENSION 1 GRANTED
Monday, November 16, 2020SOU EXTENSION 1 FILED
Monday, November 16, 2020TEAS EXTENSION RECEIVED
Tuesday, June 16, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 21, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 21, 2020PUBLISHED FOR OPPOSITION
Wednesday, April 1, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, March 16, 2020ASSIGNED TO LIE
Friday, March 6, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 6, 2020EXAMINER'S AMENDMENT ENTERED
Friday, March 6, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, March 6, 2020EXAMINERS AMENDMENT E-MAILED
Friday, March 6, 2020EXAMINERS AMENDMENT -WRITTEN
Thursday, March 5, 2020ASSIGNED TO EXAMINER
Tuesday, December 17, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 17, 2019NEW APPLICATION ENTERED

Related Keywords

optiaglar pharmaceutical preparations diabetes namely treatment